BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25091705)

  • 21. Application of direct crystallization for racemic compound propranolol hydrochloride.
    Wang X; Lu J; Ching CB
    J Pharm Sci; 2007 Oct; 96(10):2735-45. PubMed ID: 17549769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propagation of biochirality: crossovers and nonclassical crystallization kinetics of aspartic acid in water.
    Lee T; Lin YK; Tsai YC; Lee HL
    Chirality; 2013 Nov; 25(11):768-79. PubMed ID: 23873735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and selective crystallization of famotidine polymorphs.
    Lu J; Wang XJ; Yang X; Ching CB
    J Pharm Sci; 2007 Sep; 96(9):2457-68. PubMed ID: 17518361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural characterization and enantioseparation of the chiral compound praziquantel.
    Liu Y; Wang X; Wang JK; Ching CB
    J Pharm Sci; 2004 Dec; 93(12):3039-46. PubMed ID: 15514924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chiral crystallization of glutamic acid on self assembled films of cysteine.
    Dressler DH; Mastai Y
    Chirality; 2007 May; 19(5):358-65. PubMed ID: 17354265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The isolation of a metastable conglomerate using a combined computational and controlled crystallization approach.
    Davey RJ; Sadiq G; Back K; Wilkinson L; Seaton CC
    Chem Commun (Camb); 2012 Feb; 48(14):1976-8. PubMed ID: 22117223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on the metastable zone width of ketoprofen.
    Lu YH; Ching CB
    Chirality; 2006 May; 18(4):239-44. PubMed ID: 16521089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solubility, metastable zone width measurement and crystal growth of the 1:1 benzoic acid/isonicotinamide cocrystal in solutions of variable stoichiometry.
    Boyd S; Back K; Chadwick K; Davey RJ; Seaton CC
    J Pharm Sci; 2010 Sep; 99(9):3779-86. PubMed ID: 20665843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resolution of Racemic Guaifenesin Applying a Coupled Preferential Crystallization-Selective Dissolution Process: Rational Process Development.
    Temmel E; Eicke MJ; Cascella F; Seidel-Morgenstern A; Lorenz H
    Cryst Growth Des; 2019 Jun; 19(6):3148-3157. PubMed ID: 32952448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experiment and modeling for the separation of guaifenesin enantiomers using simulated moving bed and Varicol units.
    Gong R; Lin X; Li P; Yu J; Rodrigues AE
    J Chromatogr A; 2014 Oct; 1363():242-9. PubMed ID: 25047823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical-Chemical Properties of the Chiral Fungicide Fenamidone and Strategies for Enantioselective Crystallization.
    Kort AK; Lorenz H; Seidel-Morgenstern A
    Chirality; 2016 Jun; 28(6):514-20. PubMed ID: 27225331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Online monitoring of preferential crystallization of enantiomers.
    Alvarez Rodrigo A; Lorenz H; Seidel-Morgenstern A
    Chirality; 2004 Oct; 16(8):499-508. PubMed ID: 15290684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential of different techniques of preferential crystallization for enantioseparation of racemic compound forming systems.
    Polenske D; Lorenz H; Seidel-Morgenstern A
    Chirality; 2009 Aug; 21(8):728-37. PubMed ID: 18989897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid-state properties and crystallization behavior of PHA-739521 polymorphs.
    Sun CC
    Int J Pharm; 2006 Aug; 319(1-2):114-20. PubMed ID: 16720086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racemic species of sodium ibuprofen: characterization and polymorphic relationships.
    Zhang GG; Paspal SY; Suryanarayanan R; Grant DJ
    J Pharm Sci; 2003 Jul; 92(7):1356-66. PubMed ID: 12820140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unexpected differences between D- and L- tyrosine lead to chiral enhancement in racemic mixtures.
    Shinitzky M; Nudelman F; Barda Y; Haimovitz R; Chen E; Deamer DW
    Orig Life Evol Biosph; 2002 Aug; 32(4):285-97; discussion 283. PubMed ID: 12458733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symmetry, chirality and crystalline tendency: the polymorphism of triacylglycerols.
    Craven RJ; Lencki RW
    Food Funct; 2012 Mar; 3(3):228-33. PubMed ID: 22361723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solubility properties of racemic praziquantel and its enantiomers.
    el-Arini SK; Giron D; Leuenberger H
    Pharm Dev Technol; 1998 Nov; 3(4):557-64. PubMed ID: 9834959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential Amplification of Amino Acid Enantiomeric Excess by Conglomerate and Racemic Compound: Plausible Prebiotic Route Towards Homochirality.
    Sharma A
    Orig Life Evol Biosph; 2023 Dec; 53(3-4):175-185. PubMed ID: 37831272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicomponent Chiral Quantification with Ultraviolet Circular Dichroism Spectroscopy: Ternary and Quaternary Phase Diagrams of Levetiracetam.
    Charpentier MD; Venkatramanan R; Rougeot C; Leyssens T; Johnston K; Ter Horst JH
    Mol Pharm; 2023 Jan; 20(1):616-629. PubMed ID: 36468979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.